Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-18

Clinical Trial Update: A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety and effect of a study drug in rheumatoid arthritis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eli Lilly and Company | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2019-03-18